ES Cell International generate six clinical-grade hESC lines Thursday, 29 November 2007 The use of clinical-grade human embryonic stem cells (hESCs) for cell therapy has taken an important step forward. ES Cell International (ESI) has derived the first clinical-grade hESCs by using current Good Manufacturing Practice (cGMP) and Good Tissue Practice (cGTP) respectively, according to an article in the latest issue of "Cell Stem Cell". To hasten the clinical use of hESCs, ESI and the Singapore Stem Cell Bank (SSCB) are currently working out a distribution agreement. This will provide research-grade variants of clinical-grade cell lines to academic researchers at not-for-profit institutes around the world for a fee. ESI will also provide commercial industry players and those who want to conduct clinical trials access to clinical-grade versions of hESCs, under a licence. Reference: The Generation of Six Clinical-Grade Human Embryonic Stem Cell Lines Cell Stem Cell, Vol 1, 490-494, 15 November 2007 ......... ZenMaster
For more on stem cells and cloning, go to CellNEWS at http://www.geocities.com/giantfideli/index.html
Posts
No comments:
Post a Comment